Jennifer Markey

Placeholder Person Graphic
Vault SafetyStrategy and Consulting for Veeva Systems Europe
Vice President
Jennifer Markey was previously the Global Head of R&D Safety and Regulatory IT at Janssen and has worked with many of the top pharmaceutical and biotechnology companies in the world, such as Roche, Takeda, Eli Lilly, and Pfizer. Her over 20 years of industry and consulting experience in the pharmaceutical industry includes leadership and subject matter expertise roles in safety and regulatory business and system implementations, data warehousing and analytics reporting solutions, and business strategy projects. At Veeva, she is responsible for the Vault Safety Suite strategy and associated consulting services for Europe. Jen holds a fi rst-class honors degree in computer science from Dublin City University in Ireland.

Related Articles

The Untapped Potential of AI &  Automation in Pharmacovigilance
The Untapped Potential of AI &  Automation in Pharmacovigilance

Between 2009 and 2019, the number of adverse events (AEs) for drugs and therapeutic biologic products recorded by the US FDA Adverse Event Reporting System (FAERS) increased more than 300%, from 490,032 to 2.19 million cases (as of 31 December 2019).1

  • 1US Food and Drug Administration. “FDA Adverse Events Reporting System (FAERS) Public Dashboard: Data as of December 31, 2019.”...